KCT0008372
Active, not recruiting
未知
Gut microbiome in children with gastrointestinal disease
Koera University Guro Hospital0 sites120 target enrollmentTBD
ConditionsDiseases of the digestive system
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Diseases of the digestive system
- Sponsor
- Koera University Guro Hospital
- Enrollment
- 120
- Status
- Active, not recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\) IBD patients aged 13\-25 years who were diagnosed with inflammatory bowel disease with onset under the age of 17, or undergoing treatment.
- •2\) IBS patients aged 13\-25 years who were diagnosed with irritable bowel syndrome with onset under the age of 17\.
Exclusion Criteria
- •Individuals who do not consent to participate in the study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
A study of gut microbiome in Indian children with type 1 diabetesHealth Condition 1: E109- Type 1 diabetes mellitus without complicationsCTRI/2021/08/035871Hirabai Cowasji Jehangir Medical Research Institute
Not yet recruiting
Not Applicable
Effect of mode of delivery on gut microbiota of Infants at BLDE, BijapurCTRI/2024/04/065317BLDE (Deemed to be University) Shri B.M.Patil Medical College,Hospital & Research Center
Not yet recruiting
Phase 3
sing probiotics to reduce the side effects and toxicities caused by chemoradiation treatment in patients of esophageal, colon, rectal and anal canal cancer.Health Condition 1: C211- Malignant neoplasm of anal canalHealth Condition 2: C189- Malignant neoplasm of colon, unspecifiedHealth Condition 3: C159- Malignant neoplasm of esophagus, unspecifiedHealth Condition 4: C20- Malignant neoplasm of rectumCTRI/2024/03/064552Indian Council of Medical Research
Completed
Not Applicable
Altered Faecal Microbiome and Metabolome in CT1D, AT1D and T2DType 1 Diabetes Mellitus Maturity OnsetNCT05252728Second Xiangya Hospital of Central South University372
Recruiting
Not Applicable
Investigation of the gut microbiome in patients with head and neck cancer (HNSCC) and analysis of the prognostic potential of response and tolerability of PD-1, PDL-1 immune checkpoint inhibitors in head and neck cancerhead and neck carcinomaDRKS00032481ehrstuhl für Hals-Nasen-Ohrenheilkunde Universität Witten/Herdecke50